Analyst news

• May Mobility’s SPAC Merger: Is This a Road to Nowhere for Investors?

  03-10-2026 23:03 via rocketnews.com
  
  May Mobility announced plans to become a publicly traded company through a merger with ACP Holdings Acquisition, a special purpose acquisition company trading on Nasdaq under the ticker ACGC. The transaction would value the combined entity at roughly $1.4 billion, with operations to continue under the May Mobility name and listing under MAY on the Nasdaq exchange.
  The autonomous ride-hailing sector represents a significant market opportunity. Analysts project the global robotaxi market could re
  
  Read more

• How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?

  03-10-2026 23:02 via rocketnews.com
  
  Incyte Corporation, a Wilmington-based biopharmaceutical company, has demonstrated solid stock performance relative to the broader biotech sector in recent trading periods. The company discovers, develops, and commercializes treatments for cancer, blood disorders, and immune-mediated diseases, with marketed therapies including JAKAFI for blood cancer, ICLUSIG for leukemia, PEMAZYRE for bile-duct cancer, MONJUVI/MINJUVI for lymphoma, and NIKTIMVO for fibrotic disease. The company’s market
  
  Read more

• Goldman Leads Bidding for $37 Billion Palmer Square, a CLO Powerhouse

  03-10-2026 23:02 via rocketnews.com
  
  Goldman Sachs has emerged as the leading bidder in talks to acquire Palmer Square Capital Management, a collateralized loan obligation specialist based in Kansas that manages $37 billion in assets, Bloomberg reported. While the transaction remains uncertain, the pursuit reflects Goldman’s strategic push to strengthen its position in alternative credit markets and compete more directly with established alternative asset managers.
  Collateralized loan obligations are investment vehicles comp
  
  Read more

Follow @news_analyst on Twitter!